Begin typing your search...
Dr. Reddy's CTO-6 successfully completes USFDA PAI and GMP inspections
The inspection closed with zero observations and a classification of No Action Indicated
USFDA Raises Concerns Over Cleanliness and Procedures at Dr. Reddy's Hyderabad Facility
Hyderabad: Dr Reddy's has announced that the United States Food & Drug Administration (USFDA) completed a Pre-Approval Inspection (PAI) and a routine GMP inspection at API manufacturing facility in Srikakulam, Andhra Pradesh (CTO-6).
The inspection was conducted from July 10, 2023 to July 19, 2023. The inspection closed with zero observations and a classification of No Action Indicated (NAI).
Next Story
